| Insider-Aktien | 11.690.268 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Icosavax, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ICVX / Icosavax, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ICVX / Icosavax, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | -638.668 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | -5.324.897 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | -5.543 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. By family Trust | ICVX | Common Stock | I | -129.032 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. By family Trust | ICVX | Common Stock | I | -129.032 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. By family Trust | ICVX | Common Stock | I | -525.044 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. | ICVX | Common Stock | D | -358.657 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Veneman Ann M | ICVX | Common Stock | D | -2.834 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Veneman Ann M | ICVX | Common Stock | D | -11.209 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Cearley Cassia | ICVX | Common Stock | D | -131.799 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | -2.917 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | -11.376 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Wassil Jim | ICVX | Common Stock | D | -7.392 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Wassil Jim | ICVX | Common Stock | D | -3.695 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | -39.367 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Shiver John W. | ICVX | Common Stock | D | -2.833 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Shiver John W. | ICVX | Common Stock | D | -8.066 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | MCDADE MARK By Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | I | -3.510.228 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | MCDADE MARK | ICVX | Common Stock | D | -55.786 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | -223.980 | 0 | ||||||
| 2024-02-02 | 2024-02-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,2924 | -15.000 | -229 | 358.657 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 15.000 | 16 | 373.657 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | -6.532 | 525.044 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 93.227 | 97 | 358.657 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 4.789 | 4 | 265.430 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,7038 | -106.373 | -1.670 | 223.980 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,0000 | 5.972 | 90 | 330.353 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 5,9000 | 11.947 | 70 | 324.381 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 1,0400 | 74.648 | 78 | 312.434 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 0,8400 | 13.806 | 12 | 237.786 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,6725 | -15.000 | -235 | 260.641 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 15.000 | 16 | 275.641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,4265 | -40.000 | -617 | 260.641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,4444 | -50.000 | -772 | 300.641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 23.343 | 20 | 350.641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 2,4700 | 40.000 | 99 | 327.298 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 102.574 | 107 | 287.298 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,4571 | -62.205 | -962 | 184.724 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 15,4650 | -4.430 | -69 | 38.037 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 15,4571 | -10.753 | -166 | 42.467 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,4571 | -11.884 | -184 | 223.980 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Cearley Cassia | ICVX | Common Stock | D | 15,4571 | -7.934 | -123 | 130.694 | ||||
| 2023-12-15 | 2023-12-13 | 4 | Cearley Cassia | ICVX | Common Stock | D | 16,0053 | -8.759 | -140 | 131.200 | ||||
| 2023-08-01 | 2023-08-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 3.000 | 3 | 246.930 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 8,8615 | -3.323 | -29 | 235.864 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 8,8615 | -11.788 | -104 | 243.930 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 8,8615 | -3.066 | -27 | 45.620 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Cearley Cassia | ICVX | Common Stock | D | 8,8615 | -1.888 | -17 | 139.959 | ||||
| 2023-07-03 | 2023-07-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 9,5862 | -2.095 | -20 | 290.054 | ||||
| 2023-07-03 | 2023-07-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 8,7413 | -14.261 | -125 | 292.149 | ||||
| 2023-07-03 | 2023-07-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 1,0400 | 16.356 | 17 | 306.410 | ||||
| 2023-05-25 | 2023-05-23 | 4 | Cearley Cassia | ICVX | Common Stock | D | 10,0000 | -10.000 | -100 | 141.847 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,5600 | -300 | -2 | 290.054 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,0785 | -20.143 | -122 | 290.354 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 1,0400 | 20.443 | 21 | 310.497 | ||||
| 2023-03-08 | 2023-03-06 | 4 | Cearley Cassia | ICVX | Common Stock | D | 7,7474 | -5.000 | -39 | 151.847 | ||||
| 2023-02-16 | 2023-02-15 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 10.677 | 11 | 255.718 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 10,6926 | -5.922 | -63 | 103.007 | ||||
| 2023-02-15 | 2023-02-14 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 10,1715 | -3.349 | -34 | 290.054 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 10,6926 | -1.522 | -16 | 293.403 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 10,6926 | -7.506 | -80 | 245.041 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 10,6926 | -1.902 | -20 | 48.686 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 10,6926 | -1.794 | -19 | 239.187 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Cearley Cassia | ICVX | Common Stock | D | 10,6926 | -1.660 | -18 | 156.847 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Russo Thomas Joseph | ICVX | Common Stock | D | 5,7700 | 1.667 | 10 | 50.588 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 5,7700 | 1.667 | 10 | 240.981 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Holtzman Douglas | ICVX | Common Stock | D | 5,7700 | 1.667 | 10 | 294.925 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Cearley Cassia | ICVX | Common Stock | D | 5,7700 | 1.667 | 10 | 158.507 | ||||
| 2023-01-31 | 2023-01-30 | 4 | Cearley Cassia | ICVX | Common Stock | D | 0,8400 | 25.102 | 21 | 156.840 | ||||
| 2023-01-27 | 2023-01-25 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 10.678 | 11 | 252.547 | ||||
| 2023-01-27 | 2023-01-25 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 2.395 | 2 | 241.869 | ||||
| 2022-12-23 | 2022-12-23 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 14.369 | 12 | 239.474 | ||||
| 2022-12-23 | 2022-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 8,9630 | -66.764 | -598 | 225.105 | ||||
| 2022-12-16 | 2022-12-15 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | 11,1443 | -19.648 | -219 | 2.792 | ||||
| 2022-09-09 | 2022-09-08 | 4 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 4,8731 | -1.813 | -9 | 108.929 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Cearley Cassia | ICVX | Common Stock | D | 6,7038 | -303 | -2 | 131.738 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Cearley Cassia | ICVX | Common Stock | D | 6,6374 | -1.118 | -7 | 132.041 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Cearley Cassia | ICVX | Common Stock | D | 7,1076 | -391 | -3 | 133.159 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 6,7038 | -495 | -3 | 48.921 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 6,6374 | -1.825 | -12 | 49.416 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 7,1076 | -639 | -5 | 51.241 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 6,7038 | -543 | -4 | 239.314 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 6,6374 | -2.001 | -13 | 239.857 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 7,1076 | -701 | -5 | 241.858 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,7038 | -453 | -3 | 293.258 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,6374 | -9.337 | -62 | 293.711 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 7,1076 | -585 | -4 | 303.048 | ||||
| 2022-08-02 | 2022-02-18 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | -20.000 | 22.440 | ||||||
| 2022-08-02 | 2022-08-02 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 6,7038 | -1.904 | -13 | 291.869 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 6,6374 | -7.017 | -47 | 293.772 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 7,1076 | -2.456 | -17 | 300.789 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Richardson Charles E | ICVX | Common Stock | D | 6,7038 | -371 | -2 | 165.168 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Richardson Charles E | ICVX | Common Stock | D | 6,6374 | -1.368 | -9 | 165.539 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Richardson Charles E | ICVX | Common Stock | D | 7,1076 | -479 | -3 | 166.907 | ||||
| 2022-07-06 | 2022-07-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 7.185 | 6 | 303.245 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Wassil Jim | ICVX | Common Stock | D | 11.087 | 11.087 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | Veneman Ann M | ICVX | Common Stock | D | 5.543 | 14.043 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | Shiver John W. | ICVX | Common Stock | D | 2.399 | 10.899 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | 5.543 | 14.293 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | 5.543 | 5.543 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | MCDADE MARK | ICVX | Common Stock | D | 5.543 | 55.786 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | MCDADE MARK | ICVX | Common Stock | D | 7,1000 | 42.225 | 300 | 50.243 | ||||
| 2022-03-30 | 2022-03-28 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 0,84 | -4.789 | 55.081 | |||||
| 2022-03-30 | 2022-03-28 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 4.789 | 4 | 220.482 | ||||
| 2022-03-30 | 2022-03-29 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 4,7496 | 8.900 | 42 | 5.963.565 | ||||
| 2022-03-30 | 2022-03-28 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 4,5324 | 175.318 | 795 | 5.953.665 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Cearley Cassia | ICVX | Stock Option (Right to Buy) | D | 0,84 | -35.137 | 27.613 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Cearley Cassia | ICVX | Common Stock | D | 0,8400 | 35.137 | 30 | 133.550 | ||||
| 2022-03-09 | 2022-03-07 | 4 | Cearley Cassia | ICVX | Common Stock | D | 17,8100 | -484 | -9 | 98.413 | ||||
| 2022-03-09 | 2022-03-07 | 4 | Cearley Cassia | ICVX | Common Stock | D | 17,1300 | -9.516 | -163 | 98.897 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Stock Option (Right to Buy) | D | 1,04 | -6.186 | 16.657 | |||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Stock Option (Right to Buy) | D | 0,84 | -66.375 | 43.489 | |||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Common Stock | D | 1,0400 | 6.186 | 6 | 167.386 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Common Stock | D | 0,8400 | 66.375 | 56 | 161.200 | ||||
| 2022-02-14 | 2022-02-10 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 17,55 | 317.866 | 317.866 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 75.578 | 291.271 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Russo Thomas Joseph | ICVX | Stock Option (Right to Buy) | D | 17,55 | 74.500 | 74.500 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 17.714 | 51.880 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Kanesa-thasan Niranjan | ICVX | Stock Option | D | 17,55 | 81.950 | 81.950 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 19.485 | 242.559 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Richardson Charles E | ICVX | Stock Option (Right to Buy) | D | 17,55 | 67.050 | 67.050 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Richardson Charles E | ICVX | Common Stock | D | 15.942 | 94.825 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Holtzman Douglas | ICVX | Stock Option (Right to Buy) | D | 17,55 | 81.950 | 81.950 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 19.485 | 303.633 | ||||||
| 2022-02-14 | 2021-12-31 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | -10.000 | 42.440 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 82.992 | 110.742 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Cearley Cassia | ICVX | Stock Option (Right to Buy) | D | 17,55 | 89.400 | 89.400 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Cearley Cassia | ICVX | Common Stock | D | 21.256 | 108.413 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Stock Option Right to Buy) | D | 1,04 | -38.947 | 116.841 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Stock Option (Right to Buy) | D | 0,84 | -13.805 | 16.317 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 1,0400 | 38.947 | 41 | 221.408 | ||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 0,8400 | 13.805 | 12 | 182.461 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 1,04 | -73.929 | 438.605 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 0,84 | -16.764 | 59.870 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 73.929 | 77 | 215.693 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 16.764 | 14 | 141.764 | ||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 125.000 | 129.032 | ||||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 125.000 | 129.032 | ||||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | -125.000 | 531.576 | ||||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | -125.000 | 531.576 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Shiver John W. | ICVX | Stock Option (Right to Buy) | D | 22,50 | 25.500 | 25.500 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Shiver John W. | ICVX | Common Stock | D | 8.500 | 8.500 | ||||||
| 2021-11-17 | 2021-11-15 | 4 | Cearley Cassia | ICVX | Stock Option (Right to Buy) | D | 0,83 | -22.598 | 62.750 | |||||
| 2021-11-17 | 2021-11-15 | 4 | Cearley Cassia | ICVX | Common Stock | D | 0,8300 | 22.598 | 19 | 85.491 | ||||
| 2021-09-21 | 3 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 27.750 | ||||||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Series B-1 Preferred Stock | I | 0,00 | -1.027.741 | 0 | |||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Series A-1 Preferred Stock | I | 0,00 | -10.400.415 | 0 | |||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Common Stock | D | 15,0000 | 133.334 | 2.000 | 2.883.329 | ||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Common Stock | D | 2.749.995 | 2.749.995 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | -1.940.306 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | -10.995.066 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 171.766 | 2.576 | 638.668 | ||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 466.902 | 466.902 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 2.494.900 | 37.424 | 5.140.679 | ||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 2.645.779 | 2.645.779 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | Cormorant Asset Management, LLC See Footnotes | ICVX | Series B-1 Convertible Preferred Stock | I | -426.393 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | Cormorant Asset Management, LLC See Footnotes | ICVX | Common Stock | I | 426.393 | 426.393 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -79.734 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -171.505 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -114.843 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -88.775 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -299.003 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -309.321 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -935.985 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -2.013.269 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -1.348.119 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -1.042.120 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -3.509.939 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -3.631.066 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 12.368 | 186 | 256.783 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 244.415 | 244.415 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 26.604 | 399 | 552.333 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 525.729 | 525.729 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 352.037 | 352.037 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 272.131 | 272.131 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 46.381 | 696 | 962.939 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 916.558 | 916.558 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 47.981 | 720 | 996.169 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 948.188 | 948.188 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -79.734 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -171.505 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -114.843 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -88.775 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -299.003 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | -309.321 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -935.985 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -2.013.269 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -1.348.119 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -1.042.120 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -3.509.939 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | -3.631.066 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 12.368 | 186 | 256.783 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 244.415 | 244.415 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 26.604 | 399 | 552.333 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 525.729 | 525.729 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 352.037 | 352.037 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 272.131 | 272.131 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 46.381 | 696 | 962.939 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 916.558 | 916.558 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 47.981 | 720 | 996.169 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 948.188 | 948.188 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | 15,0000 | 8.750 | 131 | 8.750 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Veneman Ann M | ICVX | Common Stock | D | 15,0000 | 8.500 | 128 | 8.500 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,0000 | 6.666 | 100 | 6.666 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,0000 | 41.500 | 622 | 168.656 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc | ICVX | Series B-1 Preferred Stock (par value, $0.0001) | I | 0,00 | -354.393 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc | ICVX | Series A-1 Preferred Stock (par value, $0.0001) | I | 0,00 | -12.480.498 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | ICVX | Common Stock (par value, $0.0001) | I | 15,0000 | 66.667 | 1.000 | 3.155.169 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | ICVX | Common Stock (par value, $0.0001) | I | 3.088.502 | 3.088.502 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 15,0000 | 32.500 | 488 | 32.500 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Cearley Cassia | ICVX | Common Stock | D | 15,0000 | 27.750 | 416 | 62.893 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Series B-1 Preferred Stock | I | 0,00 | -11.602 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Series A-1 Preferred Stock | I | 0,00 | -206.323 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | 52.440 | 52.440 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 15,0000 | 41.500 | 622 | 282.482 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Richardson Charles E | ICVX | Common Stock | D | 15,0000 | 27.750 | 416 | 78.883 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Series B-1 Preferred Stock | D | 0,00 | -1.275.817 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Series A-1 Preferred Stock | D | 0,00 | -12.480.498 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 15,0000 | 13.333 | 200 | 3.523.561 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 15,0000 | 8.018 | 120 | 3.518.246 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 15,0000 | 200.000 | 3.000 | 3.510.228 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 3.310.228 | 3.310.228 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,0000 | 125.000 | 1.875 | 125.000 | ||||
| 2021-07-28 | 3 | Cearley Cassia | ICVX | Common Stock | D | 35.143 | ||||||||
| 2021-07-28 | 3 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 120.490 | ||||||||
| 2021-07-28 | 3 | Yamada Tadataka | ICVX | Common Stock | D | 124.097 | ||||||||
| 2021-07-28 | 3 | Yamada Tadataka By Leslie D. Yamada 2016 Trust | ICVX | Common Stock | I | 627.229 | ||||||||
| 2021-07-28 | 3 | Holtzman Douglas | ICVX | Common Stock | D | 240.982 | ||||||||
| 2021-07-28 | 3 | Richardson Charles E | ICVX | Common Stock | D | 51.133 | ||||||||
| 2021-07-28 | 3 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 781.576 | ||||||||
| 2021-07-28 | 3 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 4.032 | ||||||||
| 2021-07-28 | 3 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 4.032 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
